Comments
Roche melanoma pill spurs growth of less harmful cancers
19.01.2012. | CHICAGO (Reuters) - A new study helps explain why up to a third of advanced melanoma patients who take Roche Holding's pill Zelboraf develop a less deadly form of skin cancer known as cutaneous squamous cell carcinoma, and even points to a potential fix....
